Meeting Details

The 47th Annual General Meeting of Ajanta Pharma Limited was held on Thursday, 16th July 2026 at 11:00 a.m. through Video Conferencing/Other Audio-Visual Means.

Shareholder Participation

  • Total number of shareholders on record date: 65,273
  • No shareholders attended in person or through proxy
  • 58 shareholders attended through video conferencing (all public shareholders)
  • 4 resolutions were passed in the meeting

Resolution Details and Voting Results

Resolution 1: Adoption of Financial Statements

Ordinary resolution to receive, consider and adopt:

a) Audited Standalone Financial Statements for FY ended 31 March 2026 with Reports of Board of Directors and Auditors

b) Audited Consolidated Financial Statements for FY ended 31 March 2026 with Report of Auditors

Voting Results:

  • Total votes polled: 111,341,500 (89.1191% of outstanding shares)
  • Votes in favor: 111,336,195 (99.9952% of votes polled)
  • Votes against: 5,305 (0.0048% of votes polled)
  • Promoter voting: 79,313,777 shares voted 100% in favor
Resolution 2: Confirmation of Interim Dividend

Ordinary resolution to confirm the interim dividend for the financial year ended 31 March 2026

Voting Results:

  • Total votes polled: 111,447,501 (89.2047% of outstanding shares)
  • Votes in favor: 111,446,583 (99.9992% of votes polled)
  • Votes against: 918 (0.0008% of votes polled)
  • Promoter voting: 79,313,777 shares voted 100% in favor
Resolution 3: Reappointment of Director

Ordinary resolution to appoint Mr. Mannalal Bhagwandas Agrawal (DIN: 00073828) who retires by rotation

Voting Results:

  • Total votes polled: 111,434,756 (89.1937% of outstanding shares)
  • Votes in favor: 109,994,994 (98.7080% of votes polled)
  • Votes against: 1,439,762 (1.2920% of votes polled)
  • 476 members voted in favor, 85 members voted against
Resolution 4: Ratification of Cost Auditor Remuneration

Ordinary resolution to consider ratification of remuneration of Cost Auditors for financial year 2026-2027

Voting Results:

  • Total votes polled: 111,434,741 (89.1937% of outstanding shares)
  • Votes in favor: 111,433,629 (99.9990% of votes polled)
  • Votes against: 1,112 (0.0010% of votes polled)
  • Promoter voting: 79,313,777 shares voted 100% in favor

Scrutinizer Report

Pramod S. Shah of Pramod S. Shah & Associates, Practising Company Secretaries, was appointed as Scrutinizer. The remote e-voting period commenced from Monday, 13th July 2026 at 09:00 a.m. and ended on Wednesday, 15th July 2026 at 5:00 p.m. through NSDL platform. The cut-off date for determining voting eligibility was Thursday, 9th July 2026.

Additional Information

The voting results have been uploaded on the company's website at www.ajantapharma.com. No invalid votes were recorded for any resolution.